|
|
 |
|
Viewing report
|
|
|
|
Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market
Best Practices LLC, Feb 2008, Pages: 48
To ensure organizational health and competitiveness, companies must continually identify optimal resource levels for their operations. This benchmark study was designed to collect key staffing and investment benchmarks for U.S. based pharmaceutical Public Affairs functions. Data from this study will allow U.S. pharmaceutical companies to assess the efficiency of their Public Affairs functions relative to their peers.
For the purposes of this benchmarking exchange, Public Affairs was divided into six work functions:
- Government Affairs (State and Federal Government Relations and Public Policy)
- Corporate Communications – External
- Corporate Communication – Internal
- Product Communications
- Corporate Social Responsibility
- Alliance Management
Note: Customized segmentation of the data is available for this report.
Key Topics
- Public Affairs: Structure and Reporting Relationships
- Public Affairs: Staffing
- Public Affairs: Investment
- Public Affairs: Consolidated Staffing and Investment Efficiency Ratios
- Lessons Learned
Key Metrics
- FTEs
- Investment Levels
- Budget per FTE
- Budget per FTE adjusted for outsourcing
- Budget as a percent of total revenue
- Budget per U.S. Brand
- Budget per U.S. Blockbuster Brand
- FTEs per U.S. Brand
- FTEs per U.S. Blockbuster Brand
- Percent of Budget Outsourced
- Public
- Public Affairs FTEs per 1,000 Total Company Employees
- Percent of Public Affairs Employees in Government Affairs
- Percent of Public Affairs Employees in Corporate Communications - External
- Percent of Public Affairs Employees in Corporate Communications - Internal
- Percent of Public Affairs Employees in Product Communications
- Percent of Public Affairs Employees in Corporate Social Responsibility
- Percent of Public Affairs Employees in Alliance Management
Methodology
This research was based on survey results from 17 participants from 15 pharmaceutical and biotechnology companies.
Industries Profiled:
Consumer Products; Diagnostic; Pharmaceutical; Biotech; Health Care
Customers who bought this item also bought
China Water Affairs Group Limited
Medical Affairs Resources, Structures and Trends
Medical Affairs: Delivering Strategic Value
Pharmaceutical Regulatory Affairs in the EU & US
Medical Affairs Excellence: Structuring, Funding, & Aligning for Global Success
Best Practices for Government Affairs and Lobbying: Video Leadership Seminar with Caren Turner of Turner Government & Public Affairs (DVD)
Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices
U.S. Sales Communications Excellence: Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications
Pharmaceutical Pricing, Reimbursement, and Regulatory Affairs News in the Fourth Quarter of 2004
Nordic IT Resources Spending – Allocation & Trends
Government Technology - Fostering Interoperability in Public Safety Communications (Review Report)
IT Resources Spending – Allocation & Trends: Large Nordic companies 2008-2009
|
|
|
|
